Summary
Updated Aug 30, 2026
Pablo G. Legorreta is CEO, Chairman of the Board, Director of Royalty Pharma plc (RPRX). 6 SEC Form 4 filings on record going back to 2025, most recently on 7 August 2026.
Recent Transactions
5Every recent SEC Form 4 transaction Pablo G. Legorreta has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Pablo G. Legorreta files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Terrance P. Coyne - $33.61M of RPRX open-market activity in the last 12 months
- Christopher Hite - $21.50M of RPRX open-market activity in the last 12 months
- George W. Lloyd - $9.57M of RPRX open-market activity in the last 12 months
- Marshall Urist - $6.54M of RPRX open-market activity in the last 12 months
- Gregory Norden - $161K of RPRX open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Pablo G. Legorreta?
Pablo G. Legorreta is a corporate insider, tracked as CEO, Chairman of the Board, Director of Royalty Pharma plc (RPRX). InsiderAlpha holds 6 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Pablo G. Legorreta submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Where can I see all of Pablo G. Legorreta's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Pablo G. Legorreta and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
